Page 83 - Sohini Das

Cipla launches Roche's Covid antibody cocktail in India for Rs 60k per dose

The antibody cocktail (Casirivimab and Imdevimab) is to be administered for the treatment of mild to moderate Covid-19 in adults and pediatric patients

2-DG drug for Covid-19 treatment: Here're the benefits and concerns

The idea behind using 2-DG in Covid-19 is that along with other anti-virals, it can help prevent replication of the Sars-CoV-2 virus in inflamed lung cells of Covid-19 patients

Bharat Biotech may receive Covaxin drug substance from IIL in June

The Union health ministry said recently that it expects 750 million doses of Covishield to be available between August and December.

Chemists threaten to join lockdown, seek Covid-19 vaccination on priority

The medical devices makers' industry body, too, has written to the NITI Aayog seeking vaccination on priority.

Self-use Covid-19 testing kits to be available at stores for Rs 250

Mylab's kit gets ICMR nod; labs say this won't impact demand for RT-PCR tests

SII, Bharat Biotech to get bulk of Rs 15K-crore profit pool: Report

At present, SII sells its vaccine Covishield to the Centre for Rs 150 per dose, to state governments for Rs 300 and to private hospitals for Rs 600.

Covid-19 crisis: Over no response, states relax global vaccine tender norms

BMC was the first civic body in the country to float a global tender for purchasing vaccines

Biotech cos Tzar Labs and Epigeneres to launch early-detection cancer tests

Firms claim breakthrough with their RNA-marker tech which detects cancer even in stage zero

May start vaccine exports by year end, India remains priority: Serum

Company says it never exported vaccines at the cost of the people of India

Covid-19 crisis: Pharma majors step up support to affected employees

A company spokesperson said this benefit will be over and above the existing group term insurance

Covaxin capacity scaled up to 500 million doses a year: Bharat Biotech

Vaccine effective against all emerging coronavirus variants, says study

Cipla open to forge a partnership to distribute Covid-19 vaccines in India

The company already makes and markets antiviral drugs like remdesivir, favipiravir in India apart from importing and distributing Roche's tocilizumab (Actemra)

Covid-19: Dr Reddy's rolls out Sputnik V in India at Rs 995 per dose

The imported doses of the vaccine are priced at a maximum retail price of Rs 948 plus 5 percent GST per dose, with the possibility of a lower price point when local supply begins, says DRL

2 billion Covid-19 doses a long haul, but most will be covered by December

SII aims to make 50 million doses of Covovax (the Novavax vaccine) per month at its Pune plant

India's vaccine supplies to improve as it braces for Covid-19 third wave

India has vaccinated 37.2 million people with both doses of a vaccine, and about 135.5 million have received at least the first jab

Lupin willing to take partners to bring mRNA Covid-19 vaccines to India

Executive says company is looking for tie-ups to bring in drugs like Remdesivir

Bharat Biotech trial nod a turning point for paediatric Covid-19 vaccine

Bharat Biotech has already conducted trials on children 12 years and above

FabiFlu numero uno in Indian pharma market, show April sales data

With sales of Rs 352 crore in April, this brand alone accounted for over 2 per cent of the total domestic pharma market sales of Rs 15,662 crore

Russia's Sputnik V jabs set to make India debut at private hospitals

A large vaccine consignment is expected from Russia by third week of this month

Amid supply crunch, private hospitals eyeing import of Covid-19 vaccines

Two major hospital groups, Apollo Hospitals and Fortis Healthcare, said they are open to exploring opportunities to import